To determine whether the growth factor activity in LIRKO serum is a product of hepatocytes or nonhepatic cells, we used conditioned media from cultures of primary hepatocytes (HCM), isolated from control or LIRKO mice in an in vitro cell proliferation assay

  • by

To determine whether the growth factor activity in LIRKO serum is a product of hepatocytes or nonhepatic cells, we used conditioned media from cultures of… Read More »To determine whether the growth factor activity in LIRKO serum is a product of hepatocytes or nonhepatic cells, we used conditioned media from cultures of primary hepatocytes (HCM), isolated from control or LIRKO mice in an in vitro cell proliferation assay

At E17

  • by

At E17.5, however, the number of Zic2+ RGCs and the number of Islet1/2+ cells do not differ in pigmented and albino retina at E17.5 (Figure?3D,… Read More »At E17

To test whether this result was the result of lack of global phosphate availability due to decreased ATP production, the manifestation of a set of IL-2/STAT5 dependent genes (and gene promoters

  • by

To test whether this result was the result of lack of global phosphate availability due to decreased ATP production, the manifestation of a set of… Read More »To test whether this result was the result of lack of global phosphate availability due to decreased ATP production, the manifestation of a set of IL-2/STAT5 dependent genes (and gene promoters

Additionally, future optimization of iPSC-CM maturation, functional tissue engineering and culture conditions should result in the establishment of even more predictive iPSC-CM disease models that even more closely mimic the condition

  • by

Additionally, future optimization of iPSC-CM maturation, functional tissue engineering and culture conditions should result in the establishment of even more predictive iPSC-CM disease models that… Read More »Additionally, future optimization of iPSC-CM maturation, functional tissue engineering and culture conditions should result in the establishment of even more predictive iPSC-CM disease models that even more closely mimic the condition

IL-6 launch from HMC-1 cells was determined by measuring the concentration of IL-6 in the cell-free supernatants as described in Materials and Methods

  • by

IL-6 launch from HMC-1 cells was determined by measuring the concentration of IL-6 in the cell-free supernatants as described in Materials and Methods. revised Dulbecco’s… Read More »IL-6 launch from HMC-1 cells was determined by measuring the concentration of IL-6 in the cell-free supernatants as described in Materials and Methods